News Articles
What New Inflammation Research Reveals About the Future of Heart Failure Care
Us2.ai Co-founder and Non-Executive Head of Medical Affairs Dr. Carolyn Lam presented results from the POSEIDON study at ESC HF 2026, finding inflammation equally common across HF subtypes.
Us2.ai Featured at Heart Failure Congress 2026
Us2.ai's AI-powered cardiac ultrasound software featured in scientific presentations at Heart Failure Congress 2026 in Barcelona, spanning nurse-led HF screening, primary care clinical algorithm insi...
Patient Impact: How AI-Assisted Echocardiography Helped Detect Life-Threatening Heart Failure in the Community
A free community screening powered by Us2.ai's AI-assisted echocardiography detected life-threatening heart failure in Gina, 75, from Liverpool. Same day. No GP referral needed. This is the story of t...
Why Stress Is a Hidden Cardiovascular Risk for Women: Dr. Carolyn Lam in Her World
Stress isn't just burnout. For women, it's a cardiovascular risk factor that medicine has been too slow to recognise. Here's what we're missing.
Dr. Carolyn Lam Receives 2026 Women As One Mentorship Award for AI and Equity in ATTR-CM
Dr. Carolyn Lam, co-founder and Non-Executive Head of Medical Affairs at Us2.ai, has been named one of six global recipients of the 2026 Women As One Mentorship Award for her work advancing AI and equ...
Us2.ai Featured at CCPCC 2026: AI-Assisted Echo for Heart Failure
At CCPCC 2026, Dr. Kam Ka Ho Kevin of The Chinese University of Hong Kong presented the latest evidence on AI-assisted point-of-care echocardiography in chest pain and heart failure management, includ...
More Than Medicine: Dr. Carolyn Lam on Movement, Joy, and Heart Health
How Us2.ai co-founder Dr. Carolyn Lam reminds us that the heart needs more than medicine to truly thrive.
How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical Workflows
Representatives from Us2.ai and Merge sat down with the Cardiac Wire Show to discuss their new integration and what it means for the echo techs and cardiologists who use it everyday. Together, the two...
What TARTAN-HF Reveals About Diabetes and Undiagnosed Heart Failure
The results from the TARTAN-HF (Targeted assessment in high-risk patients with diabetes to identify undiagnosed heart failure) trial, presented as a late-breaking featured science presentation at the ...